Istaroxime是一款潜在“first-in-class”疗法,具有双重作用机制,旨在改善心脏收缩和舒张...查看全文
$Windtree疗法(WINT)$ 内部交易: 2021-04-05,总裁 and CEO,Fraser Craig ,买入,1000普通股, $2.58
$Windtree疗法(WINT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-008400 Size: 5 KB 网页链接
$Windtree疗法(WINT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-008159 Size: 5 KB 网页链接
$Windtree疗法(WINT)$ 内部交易: 2021-03-31,Director,Huang James ,买入,150000普通股, $2.36
$Windtree疗法(WINT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-008134 Size: 6 KB 网页链接
$Windtree疗法(WINT)$ 内部交易: 2021-03-31,总裁 and CEO,Fraser Craig ,买入,500普通股, $2.32
$Windtree疗法(WINT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-007852 Size: 5 KB 网页链接
$Windtree疗法(WINT)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001437749-21-007493 Act: 34 Size: 7 MB 网页链接
$Windtree疗法(WINT)$ 8-K Current report, items 2.02, 8.01, and 9.01 Accession Number: 0001437749-21-007497 Act: 34 Size: 4 MB 网页链接
$Windtree疗法(WINT)$ 内部交易: 2021-03-25,SVP & CFO,Hamill John P. ,买入,1500普通股, $3.25